护送系统在肌缩侧面硬化症和多发性硬化症中的假定作用和治疗潜力
Leila Noori1,2, Vahid Saqagandomabadi1, Valentina Di Felice1
1Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, 90127 Palermo, Italy.
Cells
|February 9, 2024
概括
护送系统 (CS) 涉及于肌缩性侧面硬化症 (ALS) 和多发性硬化症 (MS). 了解CS功能障碍是开发这些神经退行性疾病的新诊断和治疗方法的关键.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 陪伴系统 (CS) 在维持蛋白质平衡中起着至关重要的作用.
- 脑神经系统中的功能障碍越来越多地与神经退行性疾病的发病有关,例如肌缩侧面硬化症 (ALS) 和多发性硬化症 (MS).
- 分子陪伴物,包括热冲击蛋白 (Hsps),是具有细胞保护功能的关键CS组件,但它们的异常可能是致病性.
研究的目的:
- 审查CS在ALS和MS中的致病作用和治疗潜力.
- 建立一个基础,研究CS组件的诊断和治疗应用.
- 确定参与ALS和MS病原发生的特定CS成员.
主要方法:
- 关于ALS和MS的陪伴系统现有研究的文献综述.
- 对CS成员生理和病理生理学角色的分析.
- 识别涉及的CS组件及其功能.
主要成果:
- 有证据表明,脑脊髓功能障碍有助于ALS和MS的发病.
- 特定的CS成员被确定为可能与这些疾病有关.
- CS组件具有与疾病相关的规范性 (蛋白质平衡) 和非规范性功能.
结论:
- CS组件是理解和潜在治疗ALS和MS的关键目标.
- 为了诊断和治疗的进步,需要对CS生理学和病理生理学的进一步研究.
- 除了蛋白质平衡之外,CS中的异常可能是ALS和MS疾病进展的基础.
相关概念视频
Molecular Chaperones and Protein Folding
18.0K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
18.0K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Parkinson's Disease: Overview
546
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
546
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


